Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NIH × abrysvo × Lymphoid × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

Cyclophosphamide 127 Vincristine 99 Rituximab 95 Doxorubicin 82 Etoposide 74 Prednisone 66 Cytarabine 61 Filgrastim 60 Specimen Handling 54 Biopsy 52 Methotrexate 49 Magnetic Resonance Spectroscopy 46 fludarabine phosphate 45 Radiotherapy 41 Dexamethasone 41 Peripheral Blood Stem Cell Transplantation 31 Leucovorin 30 Prednisolone 27 Bortezomib 26 Ifosfamide 23 Mercaptopurine 22 merphos 20 Daunorubicin 20 Asparaginase 20 ibrutinib 19 Lenalidomide 19 prednylidene 18 deltacortene 18 Bleomycin 18 Alemtuzumab 18

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05170399 2026-02-05

Vaccine Responses in Patients With B Cell Malignancies

National Institutes of Health Clinical Center (CC)

Phase 4 Recruiting

Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡